IPO Insider



Highlighted IPO


On July 1, 2015, the IPO Teladoc, Inc. (NYSE: TDOC) opened for trading at $29.90 after pricing 8,250,000 shares of its common stock at a price to the public of $19.00 per share, above the recently expected range of $15 to $17 per share.

J.P. Morgan Securities LLC and Deutsche Bank Securities Inc. are acting as joint book-running managers for the offering. William Blair & Company, L.L.C., Wells Fargo Securities, LLC and SunTrust Robinson Humphrey, Inc. are acting as co-managers for the offering.

Teladoc is the nation's first and largest telehealth platform, delivering on-demand healthcare anytime, anywhere, via mobile devices, the internet, video and phone.


Recently Priced IPOs

Date Company Ticker Shares IPO Price Current % Underwriters
4/27/2016 Yintech Investment Holdings YIN 7.5 Mil $13.50 $13.95 3.33% Jefferies LLC, Ping An of China Securities
4/27/2016 Red Rock Resorts RRR N/A $27,250,000.00 $18.64 -100.00% Deutsche Bank, J.P. Morgan, BofA Merrill Lynch, Goldman, Sachs & Co.
4/22/2016 SecureWorks Corp. SCWX 8 Mil $14.00 $13.33 -4.79% BofA Merrill Lynch, Morgan Stanley, Goldman, Sachs & Co., J.P. Morgan, Barclays, Citigroup, Credit Suisse, RBC Capital Markets, UBS Investment Bank, Pacific Crest Securities, Stifel, SunTrust Robinson Humphrey, William Blair
4/21/2016 American Renal Associates Holdings ARA 7.5 Mil $22.00 $28.12 27.82% BofA Merrill Lynch, Barclays, Goldman, Sachs & Co
4/20/2016 MGM Growth Properties LLC MGP 50 Mil $21.00 $22.07 5.10% BofA Merrill Lynch, J.P. Morgan, Morgan Stanley, Evercore ISI
4/15/2016 BATS Global Markets, Inc. BATS 13.3 Mil $19.00 $23.71 24.79% Morgan Stanley, Citi, BofA Merrill Lynch, Credit Suisse, Goldman, Sachs & Co., J.P. Morgan
4/7/2016 Aeglea BioTherapeutics AGLE 5 Mil $10.00 $8.76 -12.40% UBS, BMO Capital Markets and Wells Fargo
3/23/2016 Corvus Pharmaceuticals, Inc. CRVS 4.7 Mil $15.00 $12.24 -18.40% Credit Suisse, Cowen and Company, Guggenheim Securities, Cantor Fitzgerald & Co., BTIG
3/3/2016 Syndax Pharmaceuticals SNDX 4.4 Mil $12.00 $13.69 14.08% Morgan Stanley and Citigroup
2/11/2016 AveXis AVXS 4.75 Mil $20.00 $25.00 25.00% Goldman, Sachs & Co. and Jefferies LLC

Upcoming IPOs

Date Company Ticker Shares Expected Price Underwriters
N/AGelesisGLSS4 MilN/APiper Jaffray, Stifel, Guggenheim
N/AAntero Resources Corp.ARN/AN/ABarclays, Citigroup, J.P. Morgan, Credit Suisse, Jefferies, Wells Fargo Securities
N/AViking TherapeuticsVKTX5 MilN/AOppenheimer & Co. and Roth Capital
N/ABicapital CorporationBICAN/AN/AJPMorgan, BofA/Merrill Lynch, Citigroup
N/ASidoti & Company, Inc.SDTIN/AN/AWR Hambrecht + Co., Sidoti & Company
N/AAnteriosANTE3.9 Mil$12-$14Stifel, RBC Capital, JMP, JMP Securities, Needham & Company
N/AHailiang Education GroupHLGN/AN/ANetwork 1 Financial Securities
N/AMultiVirMVIR4.6 Mil$12-$14RBC Capital, Nomura, Cantor Fitzgerald, LifeSci Capital
N/AHTG Molecular DiagnosticsHTGMN/AN/ALeerink Partners
N/APrincipal SolarPSWW2.5 Mil$7-$9Northland Capital Markets

Upcoming IPO

Blue Buffalo Pet Products (NASDAQ: BUFF) filed $500M IPO with the SEC. The company plans to list under symbol "BUFF" on the NASDAQ.

The offering is being led by JPMorgan and Citigroup, with Barlcys, Deutsche Bank, Morgan Stanley, Wells Fargo and LOYAL3 Securities also listed in support.

Blue Buffalo Pet Products is the fastest growing major pet food company in the United States, selling dog and cat food made with whole meats, fruits and vegetables, and other high-quality, natural ingredients. BLUE is a billion dollar brand based on sales at retail and is the #1 brand in the Wholesome Natural market segment. They currently have approximately 6% share of the overall pet food industry and feed only 2-3% of the 164 million pets in the United States.